



CONTINENCE ACROSS CONTINENTS TO UPEND STIGMA AND DEPENDENCY 
(CACTUS-D): PRELIMINARY RESULTS OF AN INTERNATIONAL RANDOMIZED 
CONTROLLED TRIAL OF A CONTINENCE PROMOTION INTERVENTION.
Abstract Text: 
Hypothesis / aims of study 
Continence problems affect one in two women over 65 but only a minority either seek care or 
implement evidence-based conservative, pharmaceutical or surgical treatments [1]. Many 
believe that incontinence is a normal part of ageing and fail to realize that simple treatments 
and self-help improve urinary symptoms.  
The CACTUS-D trial aimed to test the effectiveness of an integrated, evidence-based 
continence promotion intervention on urinary symptom improvement, quality of life, and care 
seeking among community-dwelling women aged 65 years and older suffering from 
incontinence in France, the UK, and Canada [2]. We hypothesized that women exposed to a 
community-based continence promotion intervention would experience improvements in 
urinary symptoms and incontinence-related quality of life, more frequently compared to 
women who were exposed to a general health information workshop. We planned to monitor 
the demand for care (GP visit and hospitalization). 
 
Study design, materials and methods 
CACTUS-D was an open-label cluster randomised controlled trial conducted across Canada, 
the UK, and France. Community-dwelling women were recruited via community groups (lunch 
clubs, older people’s groups, women’s institutes, church groups, etc.) or health insurance 
databases. Women were eligible if they were aged 65 years or older, reported urinary leakage 
of at least 2 times a week and were not treated for urinary incontinence in the previous year. 
The experimental intervention was an integrated evidence-based continence promotion 
workshop that used constructivist learning and behaviour change techniques to encourage 
women with incontinence to initiate evidence-based self-management. The control was a 
general health information workshop that mentioned the prevalence of incontinence, but did 
not direct participants towards self-management options. Each community group (cluster) was 
randomized 1:1 with blinded group allocation to receive either the control or experimental 
intervention. The workshop (intervention or control) was delivered to groups of 6-30 women 
as a single 45-minute interactive session. Women were asked to fill in a questionnaire 
covering risk factors and continence status prior to the workshop. Participants in the 
intervention group received a self-management booklet. Within one week of the workshop 
participants were phoned by a research assistant, blinded to the intervention, for a more 
detailed follow-up. Participants were contacted at three and six months after the workshop. 
Self-reported improvements in incontinence were measured with the Global Impression of 
Improvement questionnaire. Urinary symptoms were measured with the ICIQ-FLUTS 
questionnaire (F-score for OAB symptoms and I-score for urinary incontinence symptoms). 
Urinary specific quality of life at all time points was measured with the I-QOL. Healthcare 
resource use (hospitalisation, treatment consultation) as well as falls were measured by self-
report. 
A target sample size of 1000 was required in order to detect a 20% clinically meaningful 
difference in urinary incontinence symptoms and quality of life between groups (improvement 
by 4,74 points). Enrollment ended December 2016. Comparison of changes in incontinence 
symptoms, Quality of life, and hospitalisation rates at six-month post-workshop between the 
intervention and control groups were determined by Mann-Whitney or Fisher's Exact Test. 
Risk differences between the intervention and control groups were calculated, along with 95% 
CI. Results were disaggregated by center. 
 
Results 
Preliminary results on 810 women at the six-month endpoint are included. There were 406 
women in the intervention group and 404 in the control group. There was no significant 
difference between the 2 groups at baseline; the mean age and ranges of the women in each 
group were 77.3 and 78.7 respectively; severity of incontinence was comparable with 36% 
and 40% of women leaking urine once per day or more in the intervention group and control 
group, respectively. 
At 6-month follow-up, compared to the control group, more women exposed to the 
intervention reported an impression of improvement of their continence [38% (n= 154) 
improved versus 19% for controls (n= 78), RR= 2.0, 95% CI: 1.5/2.3, p< 0.0001]. ICIQ-FLUTS 
scores improved significantly in both groups, for F-score -1.0 [95% CI: -1.3/-0.8] and -1.0 [-
1.2/-0.7] respectively, and for I-score -1.7 [-2.0/.1.5] and -1.6 [-1.8/-1.3] respectively. The 
difference between groups was not significant for changes in OAB symptoms (difference in F-
score: -0.07 point, 95% CI: -0.4 to +0.3, p= 0.80), and for changes in incontinence symptoms 
(difference in I-score: -0.1 point, 95% CI: -0.5 to +0.2, p= 0.34) between the intervention and 
control groups.  
Urinary specific quality of life (I-QOL) was significantly improved at 6 months in both groups: 
+9.3 [+7.8/+10.9], and +9.6 points [+7.9/+11.3] respectively. Changes were similar in the 
intervention and control group (difference = -0.3 points, 95% CI: -2.5 to +2.0, p= 0.61].  
 
Changes  
at 6 months 
Overall Alberta Montréal London Poitiers 
Intervention vs. Control 
Impression of 
improvement 38 vs. 19%* 29 vs. 11%* 41 vs. 23%* 42 vs. 23%* 27 vs. 10%* 
Urinary specific 
QoL (I-QOL) +9.3 vs.+9.6 +11.9 vs. +8.5 +11.2 vs. +10.4 +9.9 vs. +11.0 +1.2 vs. +5.8 
OAB symptoms 
(F-score) -1.0 vs. -1.0 -1.2 vs. -1.2 -1.0 vs. -1.0 -1.2 vs. -1.3 -1.0 vs. -0.5 
UI symptoms  
(I-score) -1.7 vs. -1.6 -1.9 vs. -1.5 -1.9 vs. -2.0 -1.5 vs. -1.2 -1.4 vs.-0.7 
Hospitalization 
rate 5 vs. 10%* 4 vs. 2% 7 vs. 8% 5 vs. 18%* 3 vs. 12% 
Table: Changes in the intervention and control groups (% or mean, * if p< 0.05) 
 
Women in the intervention group reported significantly lower hospitalization rates in the last 3 
months than those in the control group (intervention group: 5% (n= 22) versus control group: 
10% (n= 39, RR= 0.6, 95% CI 0.3/0.9, p= 0.02).  
No differences were detectable in GP visits for UI [7% (n= 27) in the intervention group versus 
7% (n= 27) in the control group; RR = 1.0, 95% CI: 0.6/1.6, p= 0.92]. 
 
Interpretation of results 
The self-management tools delivered during the promotion workshop may explain that more 
women in the intervention group reported an impression of improvement despite no significant 
difference on symptoms. 
 
Concluding message 
A single continence promotion intervention delivered to groups of older women significantly 
induced an impression of improvement. 
There was no difference between the continence promotion and general health workshop’s 
effect on urinary incontinence severity. 
